Troy McCurry
Acute Care · Gaffney, SCNPI 1255386520
Payments from drug & device makers
Across 89 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$199
- Lilly USA, LLC$155
- Novo Nordisk$124
- Boehringer Ingelheim$105
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$83
- Novartis$76
- plus $815 from 30 others
What the payments were for
- Food & beverage$1,557100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $199 |
| Lilly USA, LLC | 10 | $155 |
| Novo Nordisk | 9 | $124 |
| Boehringer Ingelheim | 5 | $105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $83 |
| Novartis | 4 | $76 |
| Dexcom, Inc. | 3 | $65 |
| AstraZeneca | 4 | $65 |
| Pfizer | 4 | $60 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Inari Medical, Inc. | 2 | $57 |
| GSK | 3 | $50 |
| Merck | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Lucid Diagnostics Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $18 |
| Bayer | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Abbott | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Amgen | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Clarus Therapeutics Inc. | 1 | $11 |
| Genentech USA, Inc. | 1 | $9 |
How this compares
$1,557 in reported general payments places this provider in the 70th percentile of 339 acute care providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 93 | $82,664 |
| OzempicSemaglutide | 55 | $70,992 |
| Tresiba Flextouch U-200Insulin Degludec | 52 | $70,157 |
| MounjaroTirzepatide | 55 | $68,642 |
| EliquisApixaban | 78 | $56,738 |
| JanuviaSitagliptin Phosphate | 37 | $37,126 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $36,303 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $34,740 |
| LinzessLinaclotide | 35 | $30,494 |
| TopamaxTopiramate | 18 | $29,674 |
| TrintellixVortioxetine Hydrobromide | 49 | $25,659 |
| VraylarCariprazine Hcl | 18 | $25,048 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 40 | $24,698 |
| XareltoRivaroxaban | 34 | $23,800 |
| EntrestoSacubitril/Valsartan | 15 | $19,211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat, Stiolto Respimat, Trijardy Xr | $105 | $129,087178 claims |
| Novo NordiskOzempic, Rybelsus | $124 | $85,67868 claims |
| AbbVieLinzess, Vraylar, Qulipta, Synthroid | $199 | $70,01389 claims |
| Lilly USA, LLCMounjaro | $155 | $68,64255 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $50 | $59,43887 claims |
| PfizerEliquis | $60 | $56,73878 claims |
| MerckJanuvia, Janumet, Belsomra | $35 | $50,37964 claims |
| Johnson & JohnsonXarelto | $17 | $23,80034 claims |
| NovartisEntresto | $76 | $19,21115 claims |
| BayerKerendia | $17 | $7,43812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 339 acute care providers in South Carolina.
Other acute care in Gaffney
- Heather BowersGreenville$94K
- Michael GajewskiColumbia$62K
- Heather NortonMt Pleasant$57K
- Cameron ThomassonSumter$28K
- Sarah MatthewsGreenville$28K
- Micheal BungerColumbia$15K
- Robin TrauflerColumbia$12K
- Susan FunkGreenville$11K
- Linda HentzLexington$10K
- Kylie CapdevilaFlorence$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.